Strategic Alternatives cover image

How to Build and Sell a Biotech in 2024

Strategic Alternatives

CHAPTER

Intro

CEOs at the RBC Global Healthcare Conference discuss the complexities of selling biotech companies, including the importance of assets, pipelines, platforms, financing environment, and market dynamics, based on their experiences in the industry.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner